{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 460109682
| IUPAC_name = ''5-(1-cyclohexenyl)-5-ethyl-1,3-diazinane-2,4,6-trione''
| image = Cyclobarbital.svg
| width = 100
| image2 = Cyclobarbital ball-and-stick.png
| width2 = 180

<!--Clinical data-->
| Drugs.com = {{Drugs.com|international|cyclobarbital}}
| tradename =  
| pregnancy_category =
| legal_CA = Schedule IV 
| legal_DE = Anlage II
| routes_of_administration = Oral ([[Tablet (pharmacy)|tablets]])

<!--Pharmacokinetic data-->
| bioavailability = 
| metabolism = [[Hepatic]]
| elimination_half-life = 
| excretion = [[Renal]]

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 143-76-0
| ATC_prefix = N05
| ATC_suffix = CA10
| PubChem = 5838
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 5632
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 0M8A98AD9H
| KEGG_Ref = {{keggcite|changed|kegg}}
| KEGG = D07323
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 268164

<!--Chemical data-->
| C=12 | H=16 | N=2 | O=3 
| molecular_weight = 236.267 g/mol
| smiles = O=C1NC(=O)NC(=O)C1(/C2=C/CCCC2)CC
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C12H16N2O3/c1-2-12(8-6-4-3-5-7-8)9(15)13-11(17)14-10(12)16/h6H,2-5,7H2,1H3,(H2,13,14,15,16,17)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = WTYGAUXICFETTC-UHFFFAOYSA-N
}}

'''Cyclobarbital''', also known as '''cyclobarbitol''' or '''cyclobarbitone''', is a [[drug]] which is a [[barbiturate]] [[derivative (chemistry)|derivative]].<ref>{{Cite journal 
| last1 = Breimer | first1 = D. D. 
| last2 = Winten | first2 = M. A. 
| title = Pharmacokinetics and relative bioavailability of cyclobarbital calcium in man after oral administration 
| journal = European journal of clinical pharmacology 
| volume = 09 
| issue = 5–6 
| pages = 443–450 
| year = 1976 
| pmid = 989475
}}</ref> It is primarily available in fixed-dose combination with [[diazepam]] under the brand name '''Reladorm''' (100 mg cyclobarbital + 10 mg diazepam) and is used to treat [[insomnia]] in Russia.<ref>{{cite web|title=Russian State Register of Medicines. Registration Certificate: Reladorm (diazepam + cyclobarbital). Revised 02 Sep 2013|url=http://grls.rosminzdrav.ru/Grls_View_v2.aspx?idReg=2081&t=|accessdate=6 March 2016|language=Russian}}</ref>

==References==
{{reflist}}

{{Hypnotics and sedatives}}
{{GABAAR PAMs}}

[[Category:Barbiturates]]
[[Category:GABAA receptor positive allosteric modulators]]
[[Category:Cyclohexenes]]

{{sedative-stub}}